Zevia stock: GP Investments funds Zevia with USD 20 million. November 4 results test Zevia stock

Published on 10/24/2026 at 00:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Zevia guided third-quarter sales to USD 48.00 million, above USD 44.00-46.00 million. Financing for Zevia stock carries a 6 percent dividend.

Strategic funding and reporting dates

On October 22, 2026, Zevia agreed to a USD 20.00 million preferred-stock investment.
Preliminary third-quarter sales guidance reached USD 48.00 million from USD 44.00 million to USD 46.00 million.
Zevia plans to release third-quarter results on November 4, 2026, after market close.

ZVIA, US98955K1043, Illustration mit AI erstellt.

Zevia PBC agreed on October 22, 2026, to raise USD 20.00 million through convertible preferred stock sold to a fund managed by GP Investments. The financing also brought preliminary third-quarter guidance of USD 48.00 million in sales, above the previous USD 44.00 million to USD 46.00 million range, according to Business Wire.

Three dates reshape financing

On October 21, 2026, Zevia announced that third-quarter results would be released on November 4, 2026. On October 22, 2026, the company announced the USD 20.00 million investment, and on October 23, 2026, its filing disclosed an initial closing of USD 15.00 million, according to StockTitan.

What does financing mean for dilution?

The agreement covers up to 20,000 Series A preferred shares, with an initial conversion price of USD 1.448 per common share and a conversion cap of 14,428,844 shares, equal to 19.99 percent of common stock outstanding before issuance. The preferred stock carries a 6 percent annual dividend, while the initial closing issued 15,000 shares for USD 15.00 million, according to the filing.

Next reporting dates matter

The next two dated milestones are November 4, 2026, for third-quarter results, and April 15, 2027, the earliest date on which preferred dividends can begin accruing under the filing. The updated sales outlook contrasts with second-quarter net sales of USD 45.00 million and a gross margin of 49.00 percent, figures reported by Benzinga.

Execution now meets new capital

Zevia ended the second quarter with USD 28.47 million in cash and cash equivalents, while its preliminary adjusted EBITDA outlook for the third quarter is a loss of USD 0.90 million to USD 1.00 million, improved from a prior loss range of USD 3.00 million to USD 3.50 million. The company had a market capitalization of USD 92.3 million as of October 23, 2026, giving the announced investment a material balance-sheet scale.